2 dollars $AYTU Fourth Quarter Fiscal 2020 Financi
Post# of 124
Quote:
Fourth Quarter Fiscal 2020 Financials
Q4 Net Revenue increased 82% sequentially, and 766% year-over-year to $14.9 million
Highest revenue quarter to date is more than 2X entire fiscal 2019 revenue
Q4 Rx Net Revenue was $7.9 million, compared to $4.7 in Q3
Aytu BioScience, Inc. (AYTU) Stock Research Links
HPMM PCLI ZMRK OXIHF IKTO VGLS RMRK APRU NWPN SNRY MEDH